some quick analysis of these numbers now out.. with this Qtr's TCV its a 100% increase on FY24's total.. $19.2m up from $9.6m
and from the announcement..
Dr Parmjot Bains, CEO and Managing Director of ImpediMed said "We are pleased to see the hard work of the team starting to come to fruition. There were many positives in the quarter including the number of units as well as the depth and breadth of accounts and partnering with quality institutions like Legacy Health. We remain focused on executing our business plan and have built a strong pipeline that we are starting to convert. We expect to continue seeing improving results for the coming financial year”
last 4c we were told "significant increase in US sales in Q4 and for the rest of the calendar year" .. double is significant yes ..??
now as above ... PB says its expected to be improving again ..
DYOR.. accumulate...
IPD Price at posting:
4.1¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)